These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2632645)

  • 1. Effects of Daflon 500 mg on bovine vessels contractility.
    Gargouil YM; Perdrix L; Chapelain B; Gaborieau R
    Int Angiol; 1989; 8(4 Suppl):19-22. PubMed ID: 2632645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphagogue and pulsatile activities of Daflon 500 mg on canine thoracic lymph duct.
    Cotonat A; Cotonat J
    Int Angiol; 1989; 8(4 Suppl):15-8. PubMed ID: 2632644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lymphatic function of Daflon 500 mg.
    Labrid C
    Int Angiol; 1995 Sep; 14(3 Suppl 1):36-8. PubMed ID: 8919263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic properties of Daflon 500 mg.
    Labrid C
    Angiology; 1994 Jun; 45(6 Pt 2):524-30. PubMed ID: 8203782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators involved in inflammation: effects of Daflon 500 mg on their release.
    Jean T; Bodinier MC
    Angiology; 1994 Jun; 45(6 Pt 2):554-9. PubMed ID: 8203787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction.
    Juteau N; Bakri F; Pomies JP; Foulon C; Rigaudy P; Pillion G; Lange G; Genre O; Cron JP
    Int Angiol; 1995 Sep; 14(3 Suppl 1):8-13. PubMed ID: 8919257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic system and microcirculation. Proceedings of the Third International Symposium on Daflon 500 held during the First Mediterranean Congress of Angiology. Corfu, Greece, May 31, 1988.
    Int Angiol; 1989; 8(4 Suppl):1-75. PubMed ID: 2632643
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Daflon 500 mg on increased microvascular permeability in normal hamsters.
    Bouskela E; Donyo KA; Verbeuren TJ
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():22-6. PubMed ID: 8748885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the pharmacodynamic activity of daflon 500 mg].
    Amiel M; Barbe R
    Ann Cardiol Angeiol (Paris); 1998 Mar; 47(3):185-8. PubMed ID: 9772947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daflon as a cellular antioxidant and a membrane-stabilizing agent in human fibroblasts irradiated by ultraviolet A radiation.
    Santus R; Perdrix L; Haigle J; Morliere P; Maziere JC; Maziere C; Labrid C
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):200-5. PubMed ID: 1822683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
    Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
    Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Venous effect of Daflon. Clinical and pharmacological study using xenon-133-clearance].
    Klemm J
    MMW Munch Med Wochenschr; 1979 Jun; 121(26):891-2. PubMed ID: 112438
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioprotective effects of Daflon against genotoxicity induced by gamma irradiation in human cultured lymphocytes.
    Hosseinimehr SJ; Ahmadi A; Mahmoudzadeh A; Mohamadifar S
    Environ Mol Mutagen; 2009 Dec; 50(9):749-52. PubMed ID: 19472318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR; Nicolaides AN
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
    Ciolino HP; Wang TT; Yeh GC
    Cancer Res; 1998 Jul; 58(13):2754-60. PubMed ID: 9661887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Daflon 500 mg, a flavonoid drug, on neurological signs, levels of free radicals and electroretinogram in the gerbil after ischemia-reperfusion injury.
    Delbarre B; Delbarre G; Calinon F
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():27-33. PubMed ID: 8748886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary filtration and lymphatic resorption in diabetes. Application to the pharmacodynamic activity of Daflon 500 mg.
    Behar A; Valensi P; de Champvallins M; Cohen-Boulakia F; Albagli B
    Int Angiol; 1989; 8(4 Suppl):27-9. PubMed ID: 2632646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous elasticity after treatment with Daflon 500 mg.
    Ibegbuna V; Nicolaides AN; Sowade O; Leon M; Geroulakos G
    Angiology; 1997 Jan; 48(1):45-9. PubMed ID: 8995343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.